A woman with kidney cancer is to get life-prolonging drugs costing £100 a day after her father fought for her to get the treatment on the NHS.

NHS Greater Glasgow and Clyde will fund the treatment after a panel of senior health officials said Lorraine McDonald, 36, should receive the drug Torisel.

Her father Robert and Dr Rob Jones, an oncologist at the Beatson Cancer Centre in Glasgow, had gone before a trio of experts to argue she should be given the drug.

The treatment does not cure cancer but could extend Ms McDonald’s life.

If the bid had failed, she had faced covering the cost of the treatment herself or undergoing experimental medicines.

The appeal was the final chance for Ms McDonald, who lives with parents Robert and Margaret, both 58, in Airdrie, Lanarkshire.

Mr McDonald has spent hours researching the drug and written to politicians, including Prime Minister David Cameron.

She will begin the new course of treatment on Thursday.

Ms McDonald said: “I can’t thank my mum and dad and Dr Jones enough for everything they have done for me. My dad’s my hero.

“I know there is still a possibility Torisel might not work, but at least now I have a chance of a future.”

The John Lewis sales assistant was diagnosed with kidney cancer last November. She has already had radiotherapy and had a tumour removed and also a dose of Sutent – the first line treatment offered by the NHS for the treatment of kidney cancer. But doctors found the cancer had spread further along her spine.

A health board spokesman said: “Torisel is currently not licensed in the UK for use in the stage of cancer this patient has, but the panel concluded there were exceptional individual circumstances in this case.”